Semaglutide
Semaglutide injection
Semaglutide is an FDA-approved GLP-1 receptor agonist that helps regulate appetite and blood sugar levels. Clinical trials demonstrated an average weight loss of 15-20% of body weight over 68 weeks when combined with diet and exercise.
Available Dosages
A licensed physician will review your health profile and determine if this medication is appropriate for you.
Medical Information
How It Works
Semaglutide is administered as a once-weekly subcutaneous injection. Treatment typically begins with a lower dose that is gradually increased over 16-20 weeks to minimize gastrointestinal side effects. It works by mimicking the GLP-1 hormone, which targets areas of the brain that regulate appetite and food intake.
Potential Side Effects
The most common side effects include:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
- Headache
- Fatigue
- Injection site reactions
Side effects are typically mild and tend to improve as your body adjusts to the medication. Contact your healthcare provider if you experience severe or persistent side effects.